Synthetic Biologics enters exclusive option to license intellectual property for use of SYN-020 May 29, 2020
FDA clears initiation of phase II study of PB-1046 for hospitalized patients with COVID-19 May 28, 2020
First-in-human data for B-VEC in patients with recessive dystrophic epidermolysis bullosa May 28, 2020
RSS